Medidata Solutions announced that Omnicare Clinical Research has received Rave Accredited Plus, the most advanced level in Medidata’s ASPire to Win program for CROs and other service providers.
As a Rave Accredited Plus partner, Omnicare-which joined the ASPire to Win program back in January-broadens its EDC-related services. It can now offer its customers end-user training, study build, reporting, outputs, integration, and migration services for the Medidata Rave platform.
“From large, global pharmaceutical companies to specialty biotechs, our customers continue to view Medidata Rave as a critical component of the clinical development process and rely on the solution as a hub of clinical data,” said Michael Burton, Director of eClinical Solutions at Omnicare Clinical Research. “The ASPire to Win program has been instrumental in allowing us to easily and efficiently meet our customers’ needs for EDC at all phases of clinical trials.”
Medidata first announced ASPire to Win in April 2005.
Zenocutuzumab Shows Durable Efficacy in NRG1 Fusion-Positive Cancers in Phase II eNRGy Trial
February 13th 2025The Phase II eNRGy trial showed durable antitumor activity with zenocutuzumab (Bizengri) in patients with NRG1 fusion–positive cancers, particularly non-small cell lung cancer and pancreatic cancer.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
SCOPE Summit 2025: Enhancing the Patient Experience Through Site Centricity
February 12th 2025In an interview with ACT senior editor Andy Studna at SCOPE Summit, Ashley Davidson, vice president, product lead - sponsor tech strategy, Advarra, highlights the need for more site-centric approaches in study startup.